1Maheshwari A, Thulurath PJ. Cryptogenic cirrhosis and NAFLD : are theyrelated. Am J Gastroenterol ,2006,103 :664.
2Nannipieri M, Gonzales C, Baldi S, et al. Liver enzymes, the metabolicsyndrome and incident diabetes : The Mexico City Diabetes Study. Diabe-tes Care,2005,28 :1757-1762.
3Bloomgarden ZT. Definitions of the insulin resistance syndrome : the 1 stWorld Congress on the Insulin Resistance Syndrome. Diabetes Care,2004,27:824-830.
5Palekar NA. Clinical model for distinguishing nonalcoholic steatohepatitisfrom simple steatosis in patients with non-alcoholic fatty liver disease.Liver Int,2006,26:151.
6Marchesini G, Bugiansi E, Forlani G, et al. Nonalcoholic fatty liver,steatohepatitis, and the metabolic syndrome. Hepatology, 2003 , 37 : 917-923.
7Hanley AJ,Williams K,Festa A,et al. Liver markers an d development ofthe metabolic syndrome : the insulin resistance atherosclerosis study. Dia-betes ,2005,54:3140.
